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Introduction: Despite modern technology and developments in heart disease treatment and prevention,
heart disease remains the number one cause of death in America. With an inability to meet an everincreasing demand for heart transplants and the dangers of immunosuppressant drugs, any potential
alternative to cardiac transplantation must be pursued. The end goal of this research is to engineer
biocompatible tissues that are fully functional to repair or replace damaged portions of the heart following
the loss of cardiac function. Porcine hearts will be used as the scaffold, removing the native cells in a
process called decellularization, and subsequently recellularizing the scaffold by differentiating human
induced pluripotent stem cells (iPSC’s) into cardiomyocytes (CMs), fibroblasts, and other cells required
for proper cardiac function. After successfully developing the heart decellularization process (1), this
study inquires as to the ability to produce beating IPS-differentiated cardiomyocytes on the porcine
extracellular matrix.
Materials and Methods: Beating human heart tissue was created in vitro using non-immunogenic
scaffolds generated from decellularization of porcine hearts combined with CMs derived from iPSCs.
Whole porcine hearts were decellularized to create 3D scaffolds capable of supporting the human cells
mechanically and biochemically. From the left ventricle of the decellularized hearts, 300 μm thick, 10
mm round slices were prepared and mounted on glass coverslips. Human iPSCs were differentiated into
cardiac progenitors and 4 days after differentiation, these cells were seeded onto the cardiac slices.
Results and Discussion: Ten days after recellularization, clusters of differentiated cardiomyocytes started
to beat spontaneously. Immunofluorescence images showed confluent coverage of CMs on the
decellularized slices and the effect of the scaffold was evident in the alignment of the CMs in the
direction of the collagen fibers. A resazurin-based viability assay showed attachment and survival of 75%
of the seeded cells up to 14 days after recellularization. The clusters continued to beat for 60 days.
Conclusions: This study demonstrated the biocompatibility of decellularized porcine hearts with human
CMs and the potential of these scaffolds for use in cardiac tissue engineering. Future studies will be
directed toward 3D perfusion recellularization of whole decellularized hearts and repopulation of the
scaffolds with fibroblasts and endothelial cells along with the CMs, as well as adding mechanical and
electrical stimulation to obtain more mature beating tissue.
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